CURATE.AI

DEVICE6 trials

Sponsors

National University Hospital, Singapore, Alexandra Hospital

Conditions

Breast CancerCardiovascular DiseasesCognitive DeclineDiabetes MellitusGastrointestinal CancerHypertensionSolid Tumor

Phase 1

PRECISE CURATE.AI Pilot Clinical Trial

National University Hospital, SingaporeSolid Tumor

Start: 2020-08-20End: 2023-08-01Target: 20Updated: 2023-03-29

Nivolumab and Pembrolizumab Dose Optimisation in Solid Tumours With CURATE.AI Platform and Sequential ctDNA Measurements

National University Hospital, SingaporeSolid Tumor

Start: 2021-08-19End: 2023-08-01Target: 10Updated: 2023-03-03

Optimizing and Personalising Azacitidine Combination Therapy for Treating Solid Tumours QPOP and CURATE.AI

RecruitingNCT05381038

National University Hospital, SingaporeBreast Cancer, Gastrointestinal Cancer, Solid Tumor

Start: 2023-02-13End: 2027-04-04Target: 10Updated: 2025-09-23

Unknown Phase

Artificial Intelligence Guided Personalised Medicine in Patients With Hypertension and Diabetes

Alexandra HospitalDiabetes Mellitus, Hypertension

Start: 2021-08-31End: 2023-01-31Target: 40Updated: 2021-07-22

CURATE.AI COR-Tx Trial for Post Brain Radiotherapy Patients

National University Hospital, SingaporeCognitive Decline

Start: 2021-06-14End: 2022-07-01Target: 15Updated: 2021-11-12

AI for Anti-hypertensive Medication Titration

Alexandra HospitalCardiovascular Diseases, Hypertension

Start: 2023-04-01End: 2024-04-20Target: 45Updated: 2023-05-06

Related Papers

CURATE.AI-assisted dose titration for anti-hypertensive personalized therapy: study protocol for a multi-arm, randomized, pilot feasibility trial using CURATE.AI (CURATE.AI ADAPT trial)

European Heart Journal - Digital Health2023-10-2411 citations

CURATE.AI COR-Tx platform as a digital therapy and digital diagnostic for cognitive function in patients with brain tumour postradiotherapy treatment: protocol for a prospective mixed-methods feasibility clinical trial

BMJ Open2023-10-019 citations

Mixed-methods clinical trial to evaluate the feasibility of the CURATE.AI optimised digital cognitive rehabilitation therapeutic (COR-Tx) in patients post brain radiotherapy.

Journal of Clinical Oncology2023-06-013 citations

PRECISE CURATE.AI: A prospective feasibility trial to dynamically modulate personalized chemotherapy dose with artificial intelligence.

Journal of Clinical Oncology2022-06-0123 citations

Abstract CT211: Personalized, rational, efficacy-driven chemotherapy dosing via an artificial intelligence system (PRECISE): A protocol for the PRECISE CURATE.AI pilot clinical trial

Cancer Research2021-07-01

Personalised, Rational, Efficacy-Driven Cancer Drug Dosing via an Artificial Intelligence SystEm (PRECISE): A Protocol for the PRECISE CURATE.AI Pilot Clinical Trial

Frontiers in Digital Health2021-03-1235 citations